AU2019904093A0 - Spirotetramat formulation - Google Patents

Spirotetramat formulation

Info

Publication number
AU2019904093A0
AU2019904093A0 AU2019904093A AU2019904093A AU2019904093A0 AU 2019904093 A0 AU2019904093 A0 AU 2019904093A0 AU 2019904093 A AU2019904093 A AU 2019904093A AU 2019904093 A AU2019904093 A AU 2019904093A AU 2019904093 A0 AU2019904093 A0 AU 2019904093A0
Authority
AU
Australia
Prior art keywords
spirotetramat
formulation
spirotetramat formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019904093A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imtrade Australia Pty Ltd
Original Assignee
Imtrade Australia Pty Ltd
Filing date
Publication date
Application filed by Imtrade Australia Pty Ltd filed Critical Imtrade Australia Pty Ltd
Publication of AU2019904093A0 publication Critical patent/AU2019904093A0/en
Priority to AU2020102857A priority Critical patent/AU2020102857A4/en
Abandoned legal-status Critical Current

Links

AU2019904093A 2019-10-30 2019-10-30 Spirotetramat formulation Abandoned AU2019904093A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2020102857A AU2020102857A4 (en) 2019-10-30 2020-10-19 Spirotetramat formulation

Publications (1)

Publication Number Publication Date
AU2019904093A0 true AU2019904093A0 (en) 2019-11-14

Family

ID=

Similar Documents

Publication Publication Date Title
EP3867745A4 (en) Hyperpiler
EP3781482A4 (en) Nano-satellite
EP3833739A4 (en) Akkermansia muciniphila
EP3973549A4 (en) Betavoltaic devices
EP4044942A4 (en) Occlusion-crossing devices
EP3976107A4 (en) Sonosensitization
IL284688A (en) Formulation
EP3980332A4 (en) Electroaerodynamic devices
EP3755678A4 (en) A bio-stimulant formulation
EP3773694A4 (en) Antibody formulation
EP3777542A4 (en) Breadmaking composition
EP4013441A4 (en) Larazotide formulations
EP3939471A4 (en) Applicator
EP3939470A4 (en) Applicator
GB201913232D0 (en) Aerosolisable formulation
AU2019904093A0 (en) Spirotetramat formulation
EP4029495A4 (en) Formulation
GB2587402B (en) Formulation
EP3958903A4 (en) Antibody formulation
EP3815704A4 (en) Formulation containing emricasan
AU2019902440A0 (en) Pesticide formulation
GB201906242D0 (en) Aerosolisable formulation
AU2019900783A0 (en) Implement
GB201900658D0 (en) Formulation
AU2020333555A1 (en) Larazotide formulations